These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28360429)

  • 1. Interleukin-20 targets podocytes and is upregulated in experimental murine diabetic nephropathy.
    Hsu YH; Li HH; Sung JM; Chen WY; Hou YC; Weng YH; Lai WT; Wu CH; Chang MS
    Exp Mol Med; 2017 Mar; 49(3):e310. PubMed ID: 28360429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions.
    Nam BY; Paeng J; Kim SH; Lee SH; Kim DH; Kang HY; Li JJ; Kwak SJ; Park JT; Yoo TH; Han SH; Kim DK; Kang SW
    Apoptosis; 2012 Jan; 17(1):1-13. PubMed ID: 22006533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
    Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
    J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-20 and IL-20R1 antibodies protect against liver fibrosis.
    Chiu YS; Wei CC; Lin YJ; Hsu YH; Chang MS
    Hepatology; 2014 Sep; 60(3):1003-14. PubMed ID: 24763901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Cyclophosphamide on Expression of MMP-9 and TGF-β1 in Renal Tissue of Rats with Diabetes Mellitus.
    Zhang Y; Wu G; Hu X; Zhang J
    Cell Biochem Biophys; 2015 Jun; 72(2):399-403. PubMed ID: 25556071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
    Zhang Y; Li H; Hao J; Zhou Y; Liu W
    Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of retinoic acid in experimental diabetic nephropathy.
    Han SY; So GA; Jee YH; Han KH; Kang YS; Kim HK; Kang SW; Han DS; Han JY; Cha DR
    Immunol Cell Biol; 2004 Dec; 82(6):568-76. PubMed ID: 15550114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-19 mediates tissue damage in murine ischemic acute kidney injury.
    Hsu YH; Li HH; Sung JM; Chen WT; Hou YC; Chang MS
    PLoS One; 2013; 8(2):e56028. PubMed ID: 23468852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
    Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G
    Diabetes; 2011 Sep; 60(9):2386-96. PubMed ID: 21810593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
    Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
    Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.
    Sanchez-Niño MD; Bozic M; Córdoba-Lanús E; Valcheva P; Gracia O; Ibarz M; Fernandez E; Navarro-Gonzalez JF; Ortiz A; Valdivielso JM
    Am J Physiol Renal Physiol; 2012 Mar; 302(6):F647-57. PubMed ID: 22169009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet transplantation restores the damage of glomerulus filtration membrane in a rat model of streptozotocin-induced diabetic nephropathy.
    Ziqiang X; Yunqiang H; Hongxing F; Jinjun W; Yong C
    J Pak Med Assoc; 2016 Mar; 66(3):296-301. PubMed ID: 26968280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy.
    Kuo HL; Huang CC; Lin TY; Lin CY
    Nephrol Dial Transplant; 2018 Feb; 33(2):248-256. PubMed ID: 28339909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
    J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of low-dose TGF-β1 in early diabetic nephropathy induced by streptozotocin.
    Ma X; Ding J; Min H; Wen Y; Gao Q
    Int Immunopharmacol; 2013 Nov; 17(3):752-8. PubMed ID: 24055008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.